Ashoo Gupta - 20 Mar 2026 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Reporting relationship: VP, Finance and Controller
Issuer ticker: FDMT
Reported as of: 20 Mar 2026
Net transaction value: -$3,358
SEC form: 4
Accepted by SEC: 24 Mar 2026, 18:30:41 UTC
Prior SEC filing: 23 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Scott Bizily as Attorney-in-Fact for Ashoo Gupta

Key filing fact

Ashoo Gupta filed Form 4 for 4D Molecular Therapeutics, Inc. (FDMT) on 24 Mar 2026.

Key facts

This page summarizes Ashoo Gupta's Form 4 filing for 4D Molecular Therapeutics, Inc. (FDMT).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 24 Mar 2026, 18:30.

Change

Previous filing in this sequence was filed on 23 Dec 2025.
Current net transaction value: -$3,358.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002091461 Primary reporting owner

Gupta Ashoo

Relationship: VP, Finance and Controller
Address: C/O 4D MOLECULAR THERAPEUTICS, INC., 5858 HORTON STREET #455, EMERYVILLE
Signature: /s/ Scott Bizily as Attorney-in-Fact for Ashoo Gupta
Signature date: 24 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FDMT transaction

Common Stock

Options Exercise

Transaction value
Shares: +865
Change %: +1.9%
Price
Shares after: 47,224
Date: 20 Mar 2026
Ownership: Direct
Footnotes: F1

FDMT transaction

Common Stock

Sale

Transaction value: $2,669
Shares: -310
Change %: -0.66%
Price: $8.61
Shares after: 46,914
Date: 20 Mar 2026
Ownership: Direct
Footnotes: F2

FDMT transaction

Common Stock

Options Exercise

Transaction value
Shares: +221
Change %: +0.47%
Price
Shares after: 47,135
Date: 20 Mar 2026
Ownership: Direct
Footnotes: F1

FDMT transaction

Common Stock

Sale

Transaction value: $689
Shares: -80
Change %: -0.17%
Price: $8.61
Shares after: 47,055
Date: 20 Mar 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FDMT transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -865
Change %: -6.7%
Price: $0.000000^*
Shares after: 12,119
Date: 20 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 865
Exercise price
Footnotes: F1, F3

FDMT transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -221
Change %: -6.7%
Price: $0.000000^*
Shares after: 3,087
Date: 20 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 221
Exercise price
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Restricted Stock Units convert into common stock on a one-for-one basis.

Footnote F2

The transaction represents an automatic sale to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Footnote F3

The shares underlying the restricted stock unit award shall vest as to 25% of the shares on June 20, 2025 and as to 1/16th of the underlying shares on each quarterly anniversary of such date thereafter, while the grantee remains a service provider to the Company.

Footnote F4

The shares underlying the restricted stock unit award shall vest as to 1/16th of the shares on June 20, 2025 and as to 1/16th of the underlying shares on each quarterly anniversary of such date thereafter, while the grantee remains a service provider to the Company.